Effect of 8 weeks of combined exercise on serum levels of blood factor GDF 15 and diabetes-related indicators in elderly men with type 2 diabetes

Khani, Mostafa; Hemmati Shakarab, Soheila; Norozpour Khoshdel, Leila; Ebrahim Bahram, Mohammad; Razzaghi, Ayda

doi:10.22034/sbs.2025.520419.1139

Effect of 8 weeks of combined exercise on serum levels of blood factor GDF 15 and diabetes-related indicators in elderly men with type 2 diabetes

Document Type : Original Article

Authors

Mostafa Khani ¹

soheila hemmati shakarab ²

Leila Norozpour Khoshdel ³

Mohammad Ebrahim Bahram ⁴

Ayda Razzaghi ⁵

¹ Assistant professor, Department of Exercise Physiology, Faculty of Physical Education and Sports Sciences, Tabriz University, Tabriz, Iran

² PhD Student, Department of Exercise Physiology, Faculty of Physical Education and Sports Sciences, Tabriz University, Tabriz, Iran

³ PhD Student, Department of Exercise Physiology, , Faculty of Physical Education and Sports Sciences, Guilan University, Guilan, Iran.

⁴ PhD, Department of Exercise Physiology, faculty of psychology and education sciences Mohaghegh Ardabili University, Ardabil, Iran

⁵ MSC Student, Department of Exercise Physiology, faculty of psychology and education sciences, Mohaghegh Ardabili University, Ardabil, Iran

10.22034/sbs.2025.520419.1139

Abstract

Introduction and Purpose: Serum Growth Differentiation Factor-15 (GDF-15) is elevated in pathological conditions such as type 2 diabetes. This study investigated the effects of an eight-week combined training program (aerobic + resistance) on serum GDF-15 and diabetes-related indices in elderly men with type 2 diabetes.
Materials and Methods: Sixteen elderly men with type 2 diabetes (66.50 ± 1.41 years) were randomly assigned to a combined training group or a control group. The intervention included three 90-minute sessions per week for eight weeks (warm-up, 10–30 min aerobic exercise, and 30–40 min resistance exercise). Serum GDF-15, glucose, insulin, and insulin resistance were measured pre- and post-intervention. Data were analyzed using paired t-tests and ANCOVA (p < 0.05).
Results: ANCOVA revealed significant between-group differences in GDF-15, glucose, insulin, and insulin resistance (all p = 0.001). Within-group analysis showed a significant increase in GDF-15 and reductions in glucose, insulin, and insulin resistance post-intervention (p < 0.05).
Discussion and Conclusion: Combined exercise training may enhance GDF-15 levels and improve diabetes-related indices and body composition in elderly men with type 2 diabetes.etes-related indices and improving body composition in elderly men with type 2 diabetes.

Keywords

Combined exercise

GDF-15

Elderly

Type 2 diabetes

Subjects

Exercise Physiology

Extended Abstract

1. Introduction and Purpose

The prevalence of diabetes is directly related to age and is recognized as the most common chronic disease of old age. This condition can influence the levels of Growth Differentiation Factor-15 (GDF-15). An increase in this variable may be due to the hormone's anti-inflammatory effects, which provide an overall protective effect on the disease process. Furthermore, reports indicate that elevated GDF-15 levels have a strong correlation with certain anthropometric and diabetes-related indices, where increased circulating GDF-15 has been observed in obese individuals with Type 2 Diabetes Mellitus (T2DM) due to elevated glucose and insulin levels. While exercise can increase plasma GDF-15 and improve glucose metabolism in men, the results regarding the effect of exercise training on GDF-15 are contradictory. Although studies have demonstrated the role of various types of exercise in improving and controlling T2DM and reducing inflammatory biomarkers, the effect of combined training (aerobic + resistance) on the inflammatory biomarker GDF-15 in elderly patients with T2DM has not been thoroughly investigated. Moreover, the lack of information regarding the response of this research variable in diabetic elderly individuals highlights the necessity of this study. Therefore, this research aims to investigate the effect of a period of combined training (resistance + aerobic) on the serum level of GDF-15 in elderly men with T2DM.

2. Materials and Methods

This semi-experimental study included 16 elderly men with T2DM (66.50 \pm 1.41 years) who were assigned to two groups: combined training (aerobic + resistance) and a control group. Inclusion criteria comprised: not having COVID-19, T2DM duration between 1 and 10 years, using no more than one type of oral antidiabetic drug per day (all subjects consumed an equal dose of Metformin), not receiving insulin therapy, a baseline glycosylated hemoglobin (HbA1c) level between 6.6% and 9.9%, a fasting blood glucose (FBG) level between 160 to 250\ \text{mg/dL}, and absence of cardiovascular, renal, or ocular diseases, any diabetes complications, smoking, ability to perform exercise, and no participation in regular exercise for at least 6 months prior to the study. Exclusion criteria included: unwillingness to participate, use of nutritional supplements, irregular attendance at training sessions (maximum three absences), changes in current daily medical treatment per physician’s advice (changes in the dose or type of medication), and injury. Initially, subjects' weight and height were measured using a Seca scale model, BMI was calculated as weight divided by the square of height, and finally, body fat percentage was assessed and recorded using a caliper based on the Jackson and Pollock seven-site formula. The training protocol lasted 8 weeks (3 sessions per week, 90 minutes per session), including: 10 minutes of warm-up. 10–30 minutes of aerobic training (at an intensity between 50% and 70% of maximum heart rate. 30–40 minutes of resistance training (at an intensity between 40% and 70% of one-repetition maximum (1RM)). Before each blood sampling, subjects rested in a seated position for a few minutes. Then, 10 cc of blood was rapidly drawn by a laboratory specialist from the cubital vein of the left arm between 8:00 AM and 9:00 AM. Serum GDF-15 level was measured in all subjects before and after the exercise intervention. The data were analyzed using dependent t-tests and Analysis of Covariance (ANCOVA) at a significance level of P < 0.05.

3. Results

The between-group results using ANCOVA showed a significant difference between the two groups in the values of GDF-15 (P=0.001), glucose (P=0.001), insulin (P=0.001), and insulin resistance (P=0.001) indices. The within-group findings indicated a significant increase in serum GDF-15 level and a significant decrease in glucose, insulin, and insulin resistance levels in the post-test compared to the pre-test (P < 0.05).

4. Conclusion

The results of the present study demonstrated a significant increase in Growth Differentiation Factor-15 in the experimental group after a period of combined training (resistance + aerobic). A systematic review and meta-analysis stated that acute exercise significantly increases this factor, while chronic exercise did not have a significant effect. The probable mechanism suggests that exercise leads to a transient and short-term increase in GDF-15, which may contribute to the beneficial metabolic effects of physical activity. Consistent findings can be referenced in the studies by Moghaddasi et al. (2020) and Zhang et al. (2019). Conversely, the results of this study are inconsistent with some findings, such as those of Naderi et al. (2021), where a significant decrease in this variable was found in the continuous training group compared to the pre-test in a comparison of interval and continuous training methods in women with T2DM. Regardless of the source of GDF-15 secretion, it has been shown that an exercise-induced increase in this variable may have anti-inflammatory effects and improve insulin sensitivity. This variable likely exerts different biological effects depending on the conditions that lead to its secretion, which is transiently increased in response to exercise, leading to improved insulin sensitivity and reduced inflammation. In the findings of this research, a significant increase in these indices likely occurred due to the presence of a pathological condition (T2DM) and the effect of combined exercise training. It appears that combined exercise training can be effective in reducing diabetes-related indices and body composition factors by influencing the GDF-15 factor. Despite the important clinical findings of the present study, several limitations are apparent. Due to the limited number of available studies, subgroup analyses to understand the effects of various exercise types were not feasible. This was a two-group study, which inherently limits clinical value and generalizability.

5. Acknowledgment & Funding

We hereby express our gratitude to the participants.

6. Ethical Consideration

This study was conducted in compliance with ethical guidelines and has the ethical approval number IR.UMA.REC.1401.002 from Mohaghegh Ardabili university

7. Contribution of authors

All authors have been actively participated in the process the study and writing the article.

8. Conflict of interest

The authors declare no conflict of interest.

1. Al-Lawati JA. Diabetes mellitus: a local and global public health emergency! Oman medical journal. 2017;32(3):177. doi:10.5001/omj.2017.34.

2. Asadi S. Epidemiologic transition in Iran with emphasis on the third stage of transition. Journal of Community Health Research. 2017;6(4):: 57-248. doi:https://www.magiran.com/p1784585. [In Persian].

3. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307-12. doi:10.1038/35053000.

4. Naderi A, Boruj JB, Kargarfard M, Keshavarz S. Comparison of the effects of two types of interval and continuous training on growth factor 15, pancreatic beta cell function and insulin resistance in women with type 2 diabetes. Medical journal of Mashhad University of Medical Sciences. 2021;64(2): 2681-269. doi:10.22038/mjms.2021.18500. [In Persian]

5. Wewege M, Van Den Berg R, Ward R, Keech A. The effects of high‐intensity interval training vs. moderate‐intensity continuous training on body composition in overweight and obese adults: a systematic review and meta‐analysis. Obesity reviews. 2017;18(6):635-46. doi:10.1111/obr.12532.

6. Verges B. Lipid modification in type 2 diabetes: the role of LDL and HDL. Fundamental & clinical pharmacology. 2009;23(6):681-5 doi: 10.1111/j.1472-8206.2009.00739.x.

7. Xie S, Li Q, Luk AO, Lan H-Y, Chan PK, Bayes-Genis A, et al. Major adverse cardiovascular events and mortality prediction by circulating GDF-15 in patients with type 2 diabetes: a systematic review and meta-analysis. Biomolecules. 2022;12(7):934. doi:10.3390/biom12070934.

8. Johnen H, Kuffner T, Brown DA, Wu BJ, Stocker R, Breit SN. Increased expression of the TGF-b superfamily cytokine MIC-1/GDF15 protects ApoE−/− mice from the development of atherosclerosis. Cardiovascular Pathology. 2012;21(6):499-505. doi:10.1038/nm1677.

9. Ding Q, Mracek T, Gonzalez-Muniesa P, Kos K, Wilding J, Trayhurn P, et al. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology. 2009;150(4): 1688–1696. doi:10.1210/en.2008-0952.

10. Rochette L, Zeller M, Cottin Y, Vergely C. Insights into mechanisms of GDF15 and receptor GFRAL: therapeutic targets. Trends in Endocrinology & Metabolism. 2020;31(12):939-51. doi: 10.1016/j.tem.2020.10.004.

11. Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, et al. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. European heart journal. 2009;30(9):1057-65. doi:10.1093/eurheartj/ehn600.

12. Li J, Yang L, Qin W, Zhang G, Yuan J, Wang F. Adaptive induction of growth differentiation factor 15 attenuates endothelial cell apoptosis in response to high glucose stimulus. PloS one. 2013;8(6):e65549 . doi:10.1371/journal.pone.0065549.

13. Lind L, Wallentin L, Kempf T, Tapken H, Quint A, Lindahl B, et al. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. European heart journal. 2009;30(19):2346-53. doi:10.1093/eurheartj/ehp261.

14. Shin MY, Kim JM, Kang YE, Kim MK, Joung KH, Lee JH, et al. Association between growth differentiation factor 15 (GDF15) and cardiovascular risk in patients with newly diagnosed type 2 diabetes mellitus. Journal of Korean Medical Science. 2016;31(9):1413-8. doi:27510384.

15. Moradi M, Akbarnejhad A, Choobineh S, Shabkhiz F. The effect of eight weeks of intense and continuous intermittent training on GDF15 and IL6 factor levels in overweight men. Feyz Medical Sciences Journal. 2021;25(3):978-86.

doi:https://www.magiran.com/p2316203 .[In Persian]

16. Naderi L, Banaei Borojeni J, Kargarfard M, Keshavarz S. Comparison of Interval and Continuous Training on Growth Differentiation Factor 15, Pancreatic beta cell function and insulin resistance in Women with Type 2 Diabetes. medical journal of mashhad university of medical sciences. 2021;64(2):2681-91. doi:10.22038/mjms.2021.18500. [In Persian]

17. Adela R, Banerjee SK. GDF‐15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. Journal of diabetes research. 2015;2015(1):14. doi:10.1155/2015/490842.

18. Macia L, Tsai VW-W, Nguyen AD, Johnen H, Kuffner T, Shi Y-C, et al. Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PloS one. 2012;7(4):e34868. doi:10.1371/journal.pone.0034868.

19. hrysovergis K, Wang X, Kosak J, Lee S-H, Kim JS, Foley JF, et al. NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. International journal of obesity. 2014;38(12):1555-64. 10.1038/ijo.2014.27.

20. Campaigne BN, Lampman RM. Exercise in the clinical management of diabetes. (No Title). 1994. ISBN 13: doi:9780873226349

21. Malayeri SR, Abdolhay S, Behdari R, Hoseini M. The combined effect of resveratrol supplement and endurance training on IL-10 and TNF-α in type 2 diabetic rats. Razi Journal of Medical Sciences. 2019; 25(12):140-149. doi:http://rjms.iums.ac.ir/article-1-5526-en.html.

22. Rawal LB, Tapp RJ, Williams ED, Chan C, Yasin S, Oldenburg B. Prevention of type 2 diabetes and its complications in developing countries: a review. International journal of behavioral medicine. 2012;19:121-33. doi:10.1007/s12529-011-9162-9.

23. Kalofoutis C, Piperi C, Kalofoutis A, Harris F, Phoenix D, Singh J. Type II diabetes mellitus and cardiovascular risk factors: current therapeutic approaches. Experimental & Clinical Cardiology. 2007;12(1):17-28. doi:PMC2359621.

24. Church TS, Cheng YJ, Earnest CP, Barlow CE, Gibbons LW, Priest EL, et al. Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes care. 2004;27(1):83-88. doi:10.2337/diacare.27.1.83.

25. Church TS, LaMonte MJ, Barlow CE, Blair SN. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Archives of internal medicine. 2005;165(18):2114-20. doi:10.1001/archinte.165.18.2114.

26. Kanter M, Aksu F, Takir M, Kostek O, Kanter B, Oymagil A. Effects of low intensity exercise against apoptosis and oxidative stress in Streptozotocin-induced diabetic rat heart. Experimental and Clinical Endocrinology & Diabetes. 2017;125(09):583-91. doi:10.1055/s-0035-1569332.

27. Moghaddasi Y, Ghazalian F, Abediankenari S, Ebrahim K, Abednatanzi H. Effect of Aerobic and Resistance Training on GDF-15 Levels in Patients with Type 1 Diabetes. Journal of Mazandaran University of Medical Sciences. 2020;30(186):123-32. [In Persian]

28. Rangraz E, Mirzaei B, Nia FR. The effect of resistance training on serum levels of NT-proBNP, GDF-15, and markers of cardiac damage in the elderly males. International Journal of Applied Exercise Physiology. 2019;8(1):138-48. 138-148. doi:10.30472/ijaep.v8i1.329.

29. Kleinert M, Clemmensen C, Sjøberg KA, Carl CS, Jeppesen JF, Wojtaszewski JF, et al. Exercise increases circulating GDF15 in humans. Molecular metabolism. 2018;9:187-91. doi:10.1016/j.molmet.2017.12.016.

30. Munk PS, Valborgland T, Butt N, Larsen AI. Response of growth differentiation factor-15 to percutaneous coronary intervention and regular exercise training. Scandinavian Cardiovascular Journal. 2011;45(1):27-32. doi:10.3109/14017431.2010.516368.

31. Touvra A-M, Volaklis KA, Spassis AT, Zois CE, Douda HT, Kotsa K, et al. Combined strength and aerobic training increases transforming growth factor-β1 in patients with type 2 diabetes. Hormones. 2011;10(2):125-30. doi:10.14310/horm.2002.1302.

32. Bahram ME, Afroundeh R, Pourvaghar M, Seify F, Katebi L. The Effect of Mulberry leaf Extract Supplementation and Combined Exercises on Lipocalin-2, Interleukin 1 beta Levels and Diabetes-Related Metabolic Parameters in Elderly Patients With Type 2 Diabetes. Journal of Sport Biosciences. 2022;14(3):31-49. doi:http://umj.umsu.ac.ir/article-1-5824-en.html. [In Persian]

33. Medicine ACoS. ACSM's health-related physical fitness assessment manual: Lippincott Williams & Wilkins; 2013. doi:https://www.researchgate.net/publication/354309088_ACSM's_Fitness_Assessment_Manual.

34. Borg G, Borg E. A new generation of scaling methods: Level-anchored ratio scaling. Psychologica. 2001;28(1):15-45. doi:https://www.researchgate.net/publication/265726076_A_new_generation_of_scaling_methods_Level-anchored_ratio_scaling.

35. Medicine ACoS. ACSM's guidelines for exercise testing and prescription: Lippincott williams & wilkins; 2013.

36. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. British journal of nutrition. 1978;40(3):497-504. doi:10.1079/bjn19780152.

37. Khalafi M, Nosrati AG, sadat Mostafavi R, Jebelli FH. The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis. Feyz Medical Sciences Journal. 2023;27(4):461-72. doi:http://feyz.kaums.ac.ir/index.php?&slct_pg_id=10&sid=1&slc_lang=en. [In Persian]

38. Zhang H, Fealy CE, Kirwan JP. Exercise training promotes a GDF15-associated reduction in fat mass in older adults with obesity. American Journal of Physiology-Endocrinology and Metabolism. 2019;316(5): 829-836. doi:10.1152/ajpendo.00439.2018.

39. Chang JS, Namkung J. Effects of exercise intervention on mitochondrial stress biomarkers in metabolic syndrome patients: a randomized controlled trial. International journal of environmental research and public health. 2021;18(5):2242. doi:10.3390/ijerph18052242.

40. Herpich C, Franz K, Ost M, Otten L, Coleman V, Klaus S, et al. Associations between serum GDF15 concentrations, muscle mass, and strength show sex-specific differences in older hospital patients. Rejuvenation Research. 2021;24(1):14-9. doi:https://doi.org/10.1089/rej.2020.2308.

41. Khalafi M, Ghanbarpour Nosrati A, Hosseini Jebeli F. The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis. Feyz Medical Sciences Journal. 2023:27(4):461-479. doi:http://feyz.kaums.ac.ir/index.php?&slct_pg_id=10&sid=1&slc_lang=en About the journal [In Persian]

42. Laurens C, Parmar A, Murphy E, Carper D, Lair B, Maes P, et al. Growth and differentiation factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans. JCI insight. 2020;5(6): e131870. 10.1172/jci.insight.131870.

43. Campderrós L, Sánchez-Infantes D, Villarroya J, Nescolarde L, Bayès-Genis A, Cereijo R, et al. Altered GDF15 and FGF21 levels in response to strenuous exercise: a study in marathon runners. Frontiers in physiology. 2020;11:550102. doi:10.3389/fphys.2020.550102.

44. Plomgaard P, Hansen JS, Townsend LK, Gudiksen A, Secher NH, Clemmesen JO, et al. GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans. Frontiers in Endocrinology. 2022;13: 1037948. 10.3389/fendo.2022.1037948.

45. Tsai VW, Husaini Y, Sainsbury A, Brown DA, Breit SN. The MIC-1/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell metabolism. 2018;28(3):353-68. doi:10.1016/j.cmet.2018.07.018.

46. Navarro JF, Mora C, Macıéa M, Garcıéa J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. American Journal of Kidney Diseases. 2003;42(1):53-61. doi:10.1016/s0272-6386(03)00408-6.

47. Ngamjariyawat A, Cen J, Wang X, Welsh N. GDF15 protects insulin-producing beta cells against pro-inflammatory cytokines and metabolic stress via increased deamination of intracellular adenosine. International Journal of Molecular Sciences. 2024;25(2):801. doi:10.3390/ijms25020801.

48. Tchou I, Margeli A, Tsironi M, Skenderi K, Barnet M, Kanaka-Gantenbein C, et al. Growth-differentiation factor-15, endoglin and N-terminal pro-brain natriuretic peptide induction in athletes participating in an ultramarathon foot race. Biomarkers. 2009;14(6):418-22. doi:10.1080/13547500903062976.

49. Eddy AC, Trask AJ. Growth differentiation factor-15 and its role in diabetes and cardiovascular disease. Cytokine & growth factor reviews. 2021;57:11-8. doi:10.1016/j.cytogfr.2020.11.002.

50. Quist JS, Klein AB, Færch K, Beaulieu K, Rosenkilde M, Gram AS, et al. Effects of acute exercise and exercise training on plasma GDF15 concentrations and associations with appetite and cardiometabolic health in individuals with overweight or obesity–A secondary analysis of a randomized controlled trial. Appetite. 2023;182:106423. doi:10.1016/j.appet.2022.106423.

51. Seo M-W, Jung S-W, Kim S-W, Lee J-M, Jung HC, Song J-K. Effects of 16 weeks of resistance training on muscle quality and muscle growth factors in older adult women with sarcopenia: a randomized controlled trial. International journal of environmental research and public health. 2021;18(13):6762. doi:10.3390/ijerph18136762.

52. Luo J-W, Duan W-H, Song L, Yu Y-Q, Shi D-Z. A meta-analysis of growth differentiation factor-15 and prognosis in chronic heart failure. Frontiers in cardiovascular medicine. 2021;8: 630818. doi:10.1021/jacs.7b10864.

53. Mullican SE, Lin-Schmidt X, Chin C-N, Chavez JA, Furman JL, Armstrong AA, et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nature medicine. 2017;23(10): 1150-7. doi:10.1038/nm.4392.

54. Yalcin MM, Altinova AE, Akturk M, Gulbahar O, Arslan E, Ors Sendogan D, et al. GDF‐15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance. Journal of Diabetes Research. 2016;2016(1): 1240843. doi:10.1155/2016/1240843.

55. Silva FM, Duarte-Mendes P, Teixeira AM, Soares CM, Ferreira JP. The effects of combined exercise training on glucose metabolism and inflammatory markers in sedentary adults: a systematic review and meta-analysis. Scientific Reports. 2024;14(1): 1936. doi:10.1038/s41598-024-51832-y.

56. Pérez-López A, Gonzalo-Encabo P, Pérez-Köhler B, García-Honduvilla N, Valadés D. Circulating myokines IL-6, IL-15 and FGF21 response to training is altered by exercise type but not by menopause in women with obesity. European Journal of Sport Science. 2022;22(9): 1426-35. doi:10.1080/17461391.2021.1939430.

57. Amaro-Gahete FJ, Ponce-González JG, Corral-Pérez J, Velázquez-Díaz D, Lavie CJ, Jiménez-Pavón D. Effect of a 12-week concurrent training intervention on cardiometabolic health in obese men: A pilot study. Frontiers in Physiology. 2021;12: 630831. doi:10.3389/fphys.2021.630831.

58. Hara T, Fujiwara H, Nakao H, Mimura T, Yoshikawa T, Fujimoto S. Body composition is related to increase in plasma adiponectin levels rather than training in young obese men. European journal of applied physiology. 2005;94:520-6. doi:10.1007/s00421-005-1374-8.

59. Bird SR, Hawley JA. Update on the effects of physical activity on insulin sensitivity in humans. BMJ open sport & exercise medicine. 2017;2(1):e000143. 10.1136/bmjsem-2016-000143.

60. Moghetti P, Bacchi E, Brangani C, Donà S, Negri C. Metabolic effects of exercise. Front Horm Res. 2016;47:44-57. doi:10.1159/000445156.

61. Hawley JA, Lessard S. Exercise training‐induced improvements in insulin action. Acta physiologica. 2008;192(1):127-35. 10.1111/j.1748-1716.2007.01783.x.

62. Paquin J, Lagacé J-C, Brochu M, Dionne IJ. Exercising for insulin sensitivity–is there a mechanistic relationship with quantitative changes in skeletal muscle mass? Frontiers in Physiology. 2021;12: 656909. doi:10.3389/fphys.2021.656909.

63. Azarbayjani MA, Abedi B, Peeri M, Rasaee MJ, Stannard SR. Effects of combined aerobic and resistant training on lipid profile and glycemic control in sedentary men. Internal Medicine Journal. 2014;21(2): 132-6. doi:https://www.researchgate.net/publication/267032330_Effects_of_combined_aerobic_and_resistant_training_on_lipid_profile_and_glycemic_control_in_sedentary_men. [In Persian].

64. Streb AR, dos Santos Leonel L, Delevatti RS, Cavaglieri CR, Del Duca GF. Effects of non-periodized and linear periodized combined exercise training on insulin resistance indicators in adults with obesity: A randomized controlled trial. Sports Medicine-Open. 2021;7: 1-11. doi:10.1186/s40798-021-00359-x

65 Mohammad Rahimi GR, Bijeh N, Rashidlamir A. Effects of exercise training on serum preptin, undercarboxylated osteocalcin and high molecular weight adiponectin in adults with metabolic syndrome. Experimental physiology. 2020;105(3): 449-59. doi:10.1113/EP088036. Epub 2020 Jan 29. [In Persian].

66. Yaribeygi H, Atkin SL, Simental‐Mendía LE, Sahebkar A. Molecular mechanisms by which aerobic exercise induces insulin sensitivity. Journal of cellular physiology. 2019;234(8): 12385-92. doi:10.1002/jcp.28066.

67. Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N, et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clinical Cancer Research. 2004; 10(7): 92-2386. doi:10.1158/1078-0432.ccr-03-0165.

68. Salvatore T, Galiero R, Caturano A, Rinaldi L, Criscuolo L, Di Martino A, et al. Current knowledge on the pathophysiology of lean/normal-weight type 2 diabetes. International Journal of Molecular Sciences. 2022; 24(1):658. doi:https://doi.org/10.3390/ijms24010658.